LifeStance Health (LFST) Change in Accured Expenses (2020 - 2026)

LifeStance Health (LFST) has 7 years of Change in Accured Expenses data on file, last reported at $9.8 million in Q1 2026.

• Change in Accured Expenses for Q1 2026 came in at $9.8 million, up 322.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.2 million (up 5.1% YoY), and the FY2025 annual result was -$5.9 million, down 139.54% from the prior year.
• Change in Accured Expenses improved to $9.8 million in Q1 2026 per LFST's latest filing, from -$2.2 million in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $17.3 million in Q2 2024 and troughed at -$17.3 million in Q4 2022.
• A 5-year average of $1.8 million and a median of $2.8 million in 2024 frame the typical range for Change in Accured Expenses.
• The sharpest annual moves came in 2022 and 2024: Change in Accured Expenses plunged 891.65% in 2022, then soared 442.84% in 2024.
• A 5-year view of Change in Accured Expenses shows it stood at -$17.3 million in 2022, then jumped by 114.98% to $2.6 million in 2023, then jumped by 83.83% to $4.8 million in 2024, then plunged by 147.05% to -$2.2 million in 2025, then surged by 536.4% to $9.8 million in 2026.
• Business Quant data shows LFST's Change in Accured Expenses at $9.8 million in Q1 2026, -$2.2 million in Q4 2025, and -$3.6 million in Q3 2025.